| abstract |
The present disclosure relates generally to compositions and preconcentrates comprising: a fatty acid oil mixture comprising at least 70% eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) or from about 25% to about 70% EPA and DHA, by weight of the fatty acid oil mixture, wherein the EPA and DHA are in a form chosen from free fatty acid, ethyl ester, and triglyceride; and at least one salicylate. The present disclosure also relates to preconcentrates of the present disclosure in a form of a self-nanoemulsifying drug delivery system (SNEDDS), a self-microemulsifying drug delivery system (SMEDDS), or a self-emulsifying drug delivery system (SEDDS). |